{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:14:59Z","timestamp":1790817299318,"version":"4.1.0"},"reference-count":188,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2015.00893","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T04:35:26Z","timestamp":1443414926000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":329,"title":["Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options"],"prefix":"10.3389","volume":"6","author":[{"given":"Ya-Ting","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"issue":"232","key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00232","article-title":"Infections caused by Stenotrophomonas maltophilia in recipients of hematopoietic stem cell transplantation","volume":"4","author":"Al-Anazi","year":"2014","journal-title":"Front. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/jac\/dkp271","article-title":"Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia","volume":"64","author":"Al-Hamad","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1128\/AAC.44.11.3079-3086.2000","article-title":"Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia","volume":"44","author":"Alonso","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00246-014-1041-0","article-title":"Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience","volume":"36","author":"Arthur","year":"2015","journal-title":"Pediatr. Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1128\/AAC.48.2.666-669.2004","article-title":"Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates","volume":"48","author":"Barbolla","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1517\/13543784.2015.1005205","article-title":"Delafloxacin for the treatment of respiratory and skin infections","volume":"24","author":"Bassetti","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/jac\/12.6.555","article-title":"Synergy with double and triple antibiotic combinations compared","volume":"12","author":"Berenbaum","year":"1983","journal-title":"J. Antimicrob. Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s10096-014-2101-3","article-title":"Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia","volume":"33","author":"Betts","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.clinthera.2013.03.022","article-title":"Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011","volume":"35","author":"Bouchillon","year":"2013","journal-title":"Clin. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1586\/14787210.2014.864553","article-title":"New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen","volume":"12","author":"Brooke","year":"2014","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/ppul.10216","article-title":"Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates","volume":"35","author":"Cant\u00f3n","year":"2003","journal-title":"Pediatr. Pulmonol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1093\/cid\/ciu706","article-title":"Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options","volume":"59","author":"Castanheira","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jmii.2012.08.014","article-title":"Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections","volume":"47","author":"Chang","year":"2014","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.1128\/AAC.00317-11","article-title":"Contribution of resistance-nodulation-division efflux pump operon smeU1-V-W-U2-X to multidrug resistance of Stenotrophomonas maltophilia","volume":"55","author":"Chen","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1128\/AAC.06053-11","article-title":"Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the tigecycline in vitro surveillance in Taiwan study, 2006 to 2010","volume":"56","author":"Chen","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2014.03.006","article-title":"Investigation of the case number of catheter-related bloodstream infection overestivated by the central line-associated bloodstream infection surveillance definition","author":"Chen","year":"2014","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1128\/AAC.01682-13","article-title":"Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?","volume":"58","author":"Cho","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1128\/AAC.32.5.782","article-title":"Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia","volume":"32","author":"Chow","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3346\/jkms.2013.28.1.62","article-title":"Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates","volume":"28","author":"Chung","year":"2013","journal-title":"J. Korean Med. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3343\/alm.2015.35.2.246","article-title":"The sul1 gene in Stenotrophomonas maltophilia with high-level resistance to trimethoprim\/sulfamethoxazole","volume":"35","author":"Chung","year":"2015","journal-title":"Ann. Lab. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/00365548.2012.732240","article-title":"Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates","volume":"45","author":"Church","year":"2013","journal-title":"Scand. J. Infect. Dis."},{"key":"B23","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; 25th Informational Supplement. CLSI Document M100-S25","author":"Clinical Laboratory Standards Institute (CLSI)","year":"2015"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1111\/ped.12352","article-title":"Stenotrophomonas maltophilia: rare cause of meningitis","volume":"56","author":"Correia","year":"2014","journal-title":"Pediatr. Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/gb-2008-9-4-r74","article-title":"The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants","volume":"9","author":"Crossman","year":"2008","journal-title":"Genome Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1462-5822.2003.00306.x","article-title":"Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces","volume":"5","author":"de Oliveira-Garcia","year":"2003","journal-title":"Cell Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/00005792-200205000-00006","article-title":"Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study","volume":"81","author":"del Toro","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1086\/598640","article-title":"Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997","volume":"29","author":"Diekema","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0732-8893(98)00162-X","article-title":"Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America)","volume":"34","author":"Doern","year":"1999","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"8.e1","DOI":"10.1016\/j.ijantimicag.2008.11.006","article-title":"Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies","volume":"34","author":"Entenza","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10096-009-0709-5","article-title":"Community-acquired Stenotrophomonas maltophilia infections: a systematic review","volume":"28","author":"Falagas","year":"2009a","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2217\/fmb.09.84","article-title":"Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature","volume":"4","author":"Falagas","year":"2009b","journal-title":"Future Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jac\/dkn301","article-title":"Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review","volume":"62","author":"Falagas","year":"2008","journal-title":"J Antimicrob. Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijantimicag.2014.01.006","article-title":"Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections","volume":"44","author":"Falagas","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ijantimicag.2014.01.032","article-title":"Ceftolozane\/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)","volume":"43","author":"Farrell","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1128\/AAC.01774-09","article-title":"Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections","volume":"54","author":"Farrell","year":"2010a","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jinf.2010.03.024","article-title":"The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)","volume":"60","author":"Farrell","year":"2010b","journal-title":"J. Infect."},{"key":"B39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.diagmicrobio.2006.07.003","article-title":"Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents","volume":"56","author":"Fedler","year":"2006a","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.diagmicrobio.2006.01.005","article-title":"Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003)","volume":"55","author":"Fedler","year":"2006b","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1128\/AAC.16.6.833","article-title":"Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination","volume":"16","author":"Felegie","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jinf.2012.01.001","article-title":"Stenotrophomonas maltophilia\u2013the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study","volume":"64","author":"Fihman","year":"2012","journal-title":"J. Infect."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1099\/jmm.0.074385-0","article-title":"Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity","volume":"63","author":"Flores-Trevi\u00f1o","year":"2014","journal-title":"J. Med. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s100960100455","article-title":"Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients","volume":"20","author":"Fluit","year":"2001a","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10096-001-8078-8","article-title":"Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998","volume":"20","author":"Fluit","year":"2001b","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0954-6111(96)90242-5","article-title":"Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients","volume":"90","author":"Fujita","year":"1996","journal-title":"Respir. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1086\/320183","article-title":"Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999)","volume":"32","author":"Gales","year":"2001a","journal-title":"Clin. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1469-0691.2005.01351.x","article-title":"Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004)","volume":"12","author":"Gales","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"B49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1128\/JCM.39.1.183-190.2001","article-title":"Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines","volume":"39","author":"Gales","year":"2001b","journal-title":"J. Clin. Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0732-8893(02)00499-6","article-title":"Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000)","volume":"44","author":"Gales","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.diagmicrobio.2007.10.017","article-title":"Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers","volume":"60","author":"Gales","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1128\/AEM.01058-14","article-title":"A function of SmeDEF, the major quinolone resistance determinant of Stenotrophomonas maltophilia, is the colonization of plant roots","volume":"80","author":"Garc\u00eda-Le\u00f3n","year":"2014a","journal-title":"Appl. Environ. Microbiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.cmi.2015.01.007","article-title":"High-level quinolone resistance is associated with the overexpression of smeVWX in Stenotrophomonas maltophilia clinical isolates","volume":"21","author":"Garc\u00eda-Le\u00f3n","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/1462-2920.12408","article-title":"Interplay between intrinsic and acquired resistance to quinolones in Stenotrophomonas maltophilia","volume":"16","author":"Garc\u00eda-Le\u00f3n","year":"2014b","journal-title":"Environ. Microbiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0732-8893(02)00443-1","article-title":"Synergy of colistin with rifampin and trimethoprim\/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia","volume":"44","author":"Giamarellos-Bourboulis","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1128\/AAC.01020-12","article-title":"Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia","volume":"57","author":"Gould","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B57","first-page":"166","article-title":"Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007","volume":"21","author":"Guembe","year":"2008","journal-title":"Rev. Esp. Quimioter."},{"key":"B58","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10156-010-0068-2","article-title":"Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing","volume":"16","author":"G\u00fclmez","year":"2010","journal-title":"J. Infect. Chemother."},{"key":"B59","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1469-0691.2005.01257.x","article-title":"Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish University Hospital","volume":"11","author":"G\u00fclmez","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"B60","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5863\/1551-6776-18.2.137","article-title":"Stenotrophomonas infection in a patient with glucose-6-phosphate dehydrogenase deficiency","volume":"18","author":"Harthan","year":"2013","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"14428","DOI":"10.1074\/jbc.M809221200","article-title":"Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF","volume":"284","author":"Hern\u00e1ndez","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0732-8893(02)00540-0","article-title":"Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)","volume":"45","author":"Hoban","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/jac\/dkr524","article-title":"Effects of clinical breakpoint changes in CLSI guidelines 2010\/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli","volume":"67","author":"Hombach","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1128\/AAC.05870-11","article-title":"In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens","volume":"56","author":"Hornsey","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e112208","DOI":"10.1371\/journal.pone.0112208","article-title":"Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species","volume":"9","author":"Hotta","year":"2014","journal-title":"PLoS ONE"},{"key":"B66","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijantimicag.2010.10.025","article-title":"Stenotrophomonas maltophilia resistance to trimethoprim\/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron","volume":"37","author":"Hu","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B67","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1179\/1973947814Y.0000000168","article-title":"Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations","volume":"26","author":"Hu","year":"2014","journal-title":"J. Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e51053","DOI":"10.1371\/journal.pone.0051053","article-title":"An inducible fusaric acid tripartite efflux pump contributes to the fusaric acid resistance in Stenotrophomonas maltophilia","volume":"7","author":"Hu","year":"2012","journal-title":"PLoS ONE"},{"key":"B69","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1517\/14656566.2015.978288","article-title":"The potential role of nemonoxacin for treatment of common infections","volume":"16","author":"Huang","year":"2015","journal-title":"Expert. Opin. Pharmacother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1093\/jac\/dkt250","article-title":"Characterization of a major facilitator superfamily (MFS) tripartite efflux pump EmrCABsm from Stenotrophomonas maltophilia","volume":"68","author":"Huang","year":"2013a","journal-title":"J. Antimicrob. Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/jac\/dkt148","article-title":"Role of the pcm-tolCsm operon in the multidrug resistance of Stenotrophomonas maltophilia","volume":"68","author":"Huang","year":"2013b","journal-title":"J. Antimicrob. Chemother."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1128\/AAC.01283-09","article-title":"AmpN-AmpG operon is essential for expression of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia","volume":"54","author":"Huang","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e111784","DOI":"10.1371\/journal.pone.0111784","article-title":"A linkage between SmeIJK efflux pump, cell envelope integrity, and sigmaE-mediated envelope stress response in Stenotrophomonas maltophilia","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS ONE"},{"key":"B74","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/JCM.32.11.2856-2857.1994","article-title":"Pneumonia caused by Stenotrophomonas maltophilia with a mucoid phenotype","volume":"32","author":"Irifune","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"B75","first-page":"1170","volume":"91","author":"Jang","year":"1992","journal-title":"Xanthomonas maltophilia"},{"key":"B76","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jmii.2013.07.002","article-title":"Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum \u03b2-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007","volume":"48","author":"Jean","year":"2015","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B77","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1086\/653053","article-title":"Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"51","author":"Jones","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0732-8893(00)00115-2","article-title":"Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)","volume":"37","author":"Jones","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1469-0691.1999.tb00432.x","article-title":"Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997)","volume":"5","author":"Jones","year":"1999a","journal-title":"Clin. Microbiol. Infect."},{"key":"B80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0732-8893(98)00158-8","article-title":"Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997","volume":"35","author":"Jones","year":"1999b","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0732-8893(97)81808-1","article-title":"Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes","volume":"29","author":"Jones","year":"1997","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0924-8579(03)00245-0","article-title":"Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001)","volume":"22","author":"Jones","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/pgmj.66.782.1090","article-title":"Pseudomonas maltophilia infections in neutropenic patients and the use of imipenem","volume":"66","author":"Kerr","year":"1990","journal-title":"Postgrad. Med. J."},{"key":"B84","first-page":"914","article-title":"In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria","volume":"24","author":"Khan","year":"2014","journal-title":"J. Coll. Physicians. Surg. Pak."},{"key":"B85","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.diagmicrobio.2013.08.011","article-title":"Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea","volume":"78","author":"Kim","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1128\/AAC.00248-09","article-title":"In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis","volume":"54","author":"King","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B87","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0732-8893(01)00281-4","article-title":"In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations","volume":"41","author":"Krueger","year":"2001","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1086\/313591","article-title":"Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis","volume":"30","author":"Labarca","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1586\/14787210.2014.894881","article-title":"Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia","volume":"12","author":"Lai","year":"2014a","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B90","first-page":"350","article-title":"Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia","volume":"37","author":"Lai","year":"2004","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B91","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/j.1469-0691.2006.01511.x","article-title":"Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients","volume":"12","author":"Lai","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"B92","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.clineuro.2013.10.020","article-title":"Non-cephalosporin-susceptible, glucose non-fermentative Gram-negative bacilli meningitis in post-neurosurgical adults: clinical characteristics and therapeutic outcome","volume":"116","author":"Lai","year":"2014b","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s10096-014-2060-8","article-title":"Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012","volume":"33","author":"Lee","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/s0924-8579(12)70007-9","article-title":"Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010","volume":"40","author":"Lee","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B95","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/jac\/dkg148","article-title":"Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia","volume":"51","author":"Li","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1128\/AAC.46.2.333-343.2002","article-title":"SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia","volume":"46","author":"Li","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1128\/AAC.01974-13","article-title":"SmeOP-TolCSm efflux pump contributes to the multidrug resistance of Stenotrophomonas maltophilia","volume":"58","author":"Lin","year":"2014a","journal-title":"Antimicrob. Agents Chemother."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1093\/jac\/dkr276","article-title":"Inactivation of mrcA gene derepresses the basal-level expression of L1 and L2 beta-lactamases in Stenotrophomonas maltophilia","volume":"66","author":"Lin","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B99","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1128\/AAC.00372-15","article-title":"SmeYZ efflux pump of Stenotrophomonas maltophilia contributes to drug resistance, virulence-related characteristics, and virulence to mice","volume":"59","author":"Lin","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B100","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1093\/jac\/dku317","article-title":"MacABCsm, an ABC-type tripartite efflux pump of Stenotrophomonas maltophilia involved in drug resistance, oxidative and envelope stress tolerances and biofilm formation","volume":"69","author":"Lin","year":"2014b","journal-title":"J. Antimicrob. Chemother."},{"key":"B101","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1073\/pnas.82.14.4620","article-title":"Regulatory components in Citrobacter freundii ampC beta-lactamase induction","volume":"82","author":"Lindberg","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B102","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/s0924-8579(12)70004-3","article-title":"In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"40","author":"Liu","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B103","doi-asserted-by":"publisher","first-page":"ii55","DOI":"10.1093\/jac\/dkn352","article-title":"Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06","volume":"62","author":"Livermore","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/jac\/dkt455","article-title":"Comparative in vitro activity of sulfametrole\/trimethoprim and sulfamethoxazole\/trimethoprim and other agents against multiresistant Gram-negative bacteria","volume":"69","author":"Livermore","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B105","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1042\/bj2720627","article-title":"Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC beta-lactamase","volume":"272","author":"Lodge","year":"1990","journal-title":"Biochem. J."},{"key":"B106","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/s0924-8579(12)70008-0","article-title":"Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"40","author":"Lu","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B108","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/jac\/dkp282","article-title":"Antibacterial activities of a fosfomycin\/tobramycin combination: a novel inhaled antibiotic for bronchiectasis","volume":"64","author":"Macleod","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"B109","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1186\/cc10036","article-title":"Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study","volume":"15","author":"Magret","year":"2011","journal-title":"Crit. Care"},{"key":"B110","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0732-8893(00)00234-0","article-title":"Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I\u2013results from the SENTRY Antimicrobial Surveillance Program (North America, 1998)","volume":"39","author":"Mathai","year":"2001","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1093\/jac\/dks091","article-title":"Antimicrobial resistance among non-fermenting Gram-negative bacteria in Saudi Arabia","volume":"67","author":"Memish","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B112","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhin.2006.07.006","article-title":"Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units)","volume":"64","author":"Meyer","year":"2006","journal-title":"J. Hosp. Infect."},{"key":"B113","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1086\/314043","article-title":"Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies","volume":"31","author":"Micozzi","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1128\/AAC.00072-12","article-title":"Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients","volume":"56","author":"Milne","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/ph6111335","article-title":"A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011","volume":"6","author":"Morrissey","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/jac\/dkq131","article-title":"Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia","volume":"65","author":"Moskowitz","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"B117","doi-asserted-by":"publisher","first-page":"e1000353","DOI":"10.1371\/journal.ppat.1000353","article-title":"Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein","volume":"5","author":"Moya","year":"2009","journal-title":"PLoS Pathog."},{"key":"B118","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/jac\/dkh128","article-title":"In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods","volume":"53","author":"Nicodemo","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B119","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10096-007-0279-3","article-title":"Antimicrobial therapy for Stenotrophomonas maltophilia infections","volume":"26","author":"Nicodemo","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3892\/etm.2012.757","article-title":"Pathogenic analysis of sputum from ventilator-associated pneumonia in a pediatric intensive care unit","volume":"5","author":"Ning","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1128\/AAC.6.4.521","article-title":"Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia","volume":"6","author":"Nord","year":"1974","journal-title":"Antimicrob. Agents Chemother."},{"key":"B122","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijid.2014.10.009","article-title":"A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections","volume":"30","author":"O'Riordan","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/AAC.00795-06","article-title":"Aph(3\u2032)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia","volume":"51","author":"Okazaki","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1128\/AAC.01485-07","article-title":"Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator","volume":"52","author":"Okazaki","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B125","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jhin.2008.05.020","article-title":"Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review","volume":"70","author":"Paez","year":"2008","journal-title":"J. Hosp. Infect."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1128\/AAC.01370-10","article-title":"In vitro and in vivo properties of BAL30376, a beta-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple beta-lactamases","volume":"55","author":"Page","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/clinids\/21.4.1032","article-title":"Stenotrophomonas maltophilia: an unusual cause of biliary sepsis","volume":"21","author":"Papadakis","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.4081\/idr.2014.5147","article-title":"A patient presenting with cholangitis due to Stenotrophomonas maltophilia and Pseudomonas aeruginosa successfully treated with intrabiliary colistin","volume":"6","author":"Perez","year":"2014","journal-title":"Infect. Dis. Rep."},{"key":"B129","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1093\/jac\/dku309","article-title":"Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin","volume":"69","author":"Personne","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B130","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jmii.2013.09.005","article-title":"Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital","volume":"48","author":"Pien","year":"2015","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B131","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.42.7.1762","article-title":"Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)","volume":"42","author":"Pfaller","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B132","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2180-10-102","article-title":"Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients","volume":"10","author":"Pompilio","year":"2010","journal-title":"BMC Microbiol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1128\/AAC.39.10.2220","article-title":"In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia","volume":"39","author":"Poulos","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"B134","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1128\/MMBR.64.4.672-693.2000","article-title":"Molecular properties of bacterial multidrug transporters","volume":"64","author":"Putman","year":"2000","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B135","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1128\/AAC.04123-14","article-title":"In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients","volume":"59","author":"Ratjen","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B136","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1471-2334-13-167","article-title":"Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria","volume":"13","author":"Rattanaumpawan","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"B137","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.diagmicrobio.2014.01.017","article-title":"In vitro activity of tigecycline against isolates collected from complicated skin and skin structure infections and intra-abdominal infections in Africa and Middle East countries: TEST 2007-2012","volume":"79","author":"Renteria","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1099\/jmm.0.053355-0","article-title":"Distinct groups and antimicrobial resistance of clinical Stenotrophomonas maltophilia complex isolates from Korea","volume":"62","author":"Rhee","year":"2013","journal-title":"J. Med. Microbiol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jiac.2014.10.009","article-title":"In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives","volume":"21","author":"Rizek","year":"2015","journal-title":"J. Infect. Chemother."},{"key":"B140","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jgar.2014.04.004","article-title":"In vitro activity of colistin against Stenotrophomonas maltophilia","volume":"2","author":"Rodr\u00edguez","year":"2014","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B141","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ijantimicag.2014.01.007","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012","volume":"43","author":"Sader","year":"2014a","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1128\/AAC.02684-13","article-title":"Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012)","volume":"58","author":"Sader","year":"2014b","journal-title":"Antimicrob. Agents Chemother."},{"key":"B143","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.diagmicrobio.2013.02.009","article-title":"Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011)","volume":"76","author":"Sader","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B144","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijantimicag.2004.10.002","article-title":"Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli","volume":"25","author":"Sader","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B145","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.diagmicrobio.2005.05.002","article-title":"Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit","volume":"52","author":"Sader","year":"2005a","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B146","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1590\/S1413-86702004000100004","article-title":"SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001","volume":"8","author":"Sader","year":"2004","journal-title":"Braz. J. Infect. Dis."},{"key":"B147","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0732-8893(98)00124-2","article-title":"Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group","volume":"32","author":"Sader","year":"1998","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B148","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.diagmicrobio.2005.05.005","article-title":"Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents","volume":"52","author":"Sader","year":"2005b","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1086\/522998","article-title":"Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer","volume":"45","author":"Safdar","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1128\/AAC.46.4.1105-1107.2002","article-title":"Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis","volume":"46","author":"Saiman","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e37375","DOI":"10.1371\/journal.pone.0037375","article-title":"Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome","volume":"7","author":"Samonis","year":"2012","journal-title":"PLoS ONE"},{"key":"B152","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1128\/AAC.48.1.168-171.2004","article-title":"Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis","volume":"48","author":"San Gabriel","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B153","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2217\/fmb.09.45","article-title":"Stenotrophomonas maltophilia drug resistance","volume":"4","author":"Sanchez","year":"2009","journal-title":"Future Microbiol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1471-2180-8-148","article-title":"Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants","volume":"8","author":"S\u00e1nchez","year":"2008","journal-title":"BMC Microbiol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1128\/AAC.00496-09","article-title":"SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia","volume":"54","author":"Sanchez","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B156","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1128\/AAC.00714-15","article-title":"The efflux pump SmeDEF contributes to trimethoprim\/sulfamethoxazole resistance in Stenotrophomonas maltophilia","volume":"59","author":"S\u00e1nchez","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B157","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1128\/AAC.00026-08","article-title":"Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia","volume":"52","author":"Shimizu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.7860\/jcdr\/2013\/5614.3248","article-title":"Meningitis due to Stenotrophomonas maltophilia after a Neurosurgical Procedure","volume":"7","author":"Sood","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"B159","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.diagmicrobio.2012.12.004","article-title":"Tigecycline: an update","volume":"75","author":"Stein","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B160","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijantimicag.2003.12.019","article-title":"Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)","volume":"24","author":"Streit","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B161","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1128\/AAC.03354-14","article-title":"Identification of a novel 6\u2032-N-aminoglycoside acetyltransferase, AAC(6\u2032)-Iak, from a multidrug-resistant clinical isolate of Stenotrophomonas maltophilia","volume":"58","author":"Tada","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B162","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1128\/AAC.01446-13","article-title":"Involvement of mutation in ampD I, mrcA, and at least one additional gene in beta-lactamase hyperproduction in Stenotrophomonas maltophilia","volume":"57","author":"Talfan","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B163","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jmii.2012.11.006","article-title":"Epidemiology and antimicrobial resistance among commonly encountered bacteria associated with infections and colonization in intensive care units in a university affiliated hospital in Shanghai","volume":"47","author":"Tan","year":"2014","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B164","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1179\/1120009X12Z.00000000022","article-title":"Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections","volume":"24","author":"Tek\u00e7e","year":"2012","journal-title":"J. Chemother."},{"key":"B165","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3201\/eid1304.061378","article-title":"Global emergence of trimethoprim\/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes","volume":"13","author":"Toleman","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1128\/AAC.45.5.1581-1584.2001","article-title":"Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains","volume":"45","author":"Valdezate","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B167","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/jac\/dki182","article-title":"Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains","volume":"56","author":"Valdezate","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"B168","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jcf.2007.06.006","article-title":"Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis","volume":"7","author":"Valenza","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"B169","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1128\/AAC.38.3.624","article-title":"A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy","volume":"38","author":"Vartivarian","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"B170","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1055\/s-2000-9859","article-title":"The clinical spectrum of Stenotrophomonas (Xanthomonas) maltophilia respiratory infection","volume":"21","author":"Vartivarian","year":"2000","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"B171","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1001\/archinte.1996.00440040111012","volume":"156","author":"Vartivarian","year":"1996","journal-title":"Stenotrophomonas (Xanthomonas) maltophilia"},{"key":"B172","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/00365549409011780","article-title":"Xanthomonas maltophilia bacteremia in immunocompromised hematological patients","volume":"26","author":"Victor","year":"1994","journal-title":"Scand. J. Infect. Dis."},{"key":"B173","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1128\/AAC.42.8.2002","article-title":"Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophilia","volume":"42","author":"Visalli","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B174","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1128\/AAC.02744-13","article-title":"In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012","volume":"58","author":"Walkty","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2014.06.005","article-title":"Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospectivestudy","author":"Wang","year":"2014a","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B176","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1128\/AAC.01324-13","article-title":"Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections","volume":"58","author":"Wang","year":"2014b","journal-title":"Antimicrob. Agents Chemother."},{"key":"B177","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2174\/138161212799315939","article-title":"New treatments for emerging cystic fibrosis pathogens other than Pseudomonas","volume":"18","author":"Waters","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1345\/aph.1P217","article-title":"Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin","volume":"44","author":"Wood","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"B179","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jmii.2011.09.028","article-title":"A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan","volume":"45","author":"Wu","year":"2012","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1128\/AAC.02215-12","article-title":"Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients","volume":"57","author":"Wu","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B181","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.3760\/cma.j.issn.0366-6999.20140364","article-title":"High-dosage tigecycline for Stenotrophomonas maltophilia bacteremia","volume":"127","author":"Wu","year":"2014","journal-title":"Chin. Med. J. (Engl.)"},{"key":"B182","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ijantimicag.2010.09.001","article-title":"Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"36","author":"Yang","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B183","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1128\/AAC.01513-08","article-title":"AmpDI is involved in expression of the chromosomal L1 and L2 beta-lactamases of Stenotrophomonas maltophilia","volume":"53","author":"Yang","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B184","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/infdis\/142.4.602","article-title":"Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia","volume":"142","author":"Yu","year":"1980","journal-title":"J. Infect. Dis."},{"key":"B185","doi-asserted-by":"publisher","first-page":"i7","DOI":"10.1093\/jac\/dkt022","article-title":"Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study","volume":"68","author":"Zhanel","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B186","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.diagmicrobio.2010.10.025","article-title":"Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 study","volume":"69","author":"Zhanel","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B187","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1128\/AAC.00469-10","article-title":"Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008)","volume":"54","author":"Zhanel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B188","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.diagmicrobio.2008.04.012","article-title":"Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005\/2006","volume":"62","author":"Zhanel","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T18:22:32Z","timestamp":1599589352000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2015.00893\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":188,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2015.00893","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}